Patient Guide: A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 174 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05083169
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma
Phase: PHASE3

Find a Study Location Near You

This study is available at 174 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Duarte, California
  • Stanford, California
  • • And 171 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily